PARIS–(BUSINESS WIRE)–Regulatory News: “ACTISAVE Clinical Trial: Efficacy and Safety of Glenzocimab on Top of Thrombolysis with or without Mechanical Thrombectomy.” Post this ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, including stroke, announces the presentation, […]
Other News
HRS 2024: Vektor Medical’s vMap Technology to be Highlighted in Rhythm Theater and Eight Posters
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today unveiled a comprehensive schedule of educational content and sessions featuring the use of vMap® at this year’s Heart Rhythm 2024 conference in Boston, May 16-19. vMap rapidly provides actionable arrhythmia localization insights for physicians. The research and presentations at HRS […]
BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected
LONDON–(BUSINESS WIRE)–BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to its discovery portfolio through its collaboration with BenevolentAI. Novel target for Heart Failure was discovered using BenevolentAI’s AI-drug […]
Simpson Interventions Accepted into FDA’s TAP Pilot Program for Breakthrough Device, Acolyte™ Catheter System
CAMPBELL, Calif.–(BUSINESS WIRE)–Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced its acceptance into the Total Product Life Cycle Advisory Program Pilot (TAP Pilot) by the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA). “This acknowledgment underscores […]
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
New research from The Cooper Institute® + partners shows exercising, even at very high levels, is unrelated to progression of coronary artery calcium (CAC)
HeartFlow’s Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
MOUNTAIN VIEW, Calif., May 15, 2024 (GLOBE NEWSWIRE) — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the data from its REVEALPLAQUE study, highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging.
Varian Announces Exclusive US Distribution Agreement with Innova Vascular for New Innovative Thrombectomy Solutions
PALO ALTO, Calif., May 15, 2024 /PRNewswire/ — Varian, a Siemens Healthineers company, has announced an exclusive US distribution agreement with Innova Vascular, Inc., a medical device company engaged in the development of innovative minimally invasive devices for treating vascular…
AbbaDox Shines at RBMA PaRADigm 2024 with Two Prestigious Awards
LAS VEGAS, May 15, 2024 /PRNewswire/ — AbbaDox proudly announced two remarkable achievements at the 2024 Radiology Business Management Association (RBMA) PaRADigm annual conference held in Las Vegas last month. Lake Medical Imaging, in partnership with AbbaDox, received the Practice…
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
Stereotaxis presents innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablati
CardioPharma Announces Issuance of Global Patent to Mitigate the World’s Top Killer
WILMINGTON, N.C., May 14, 2024 /PRNewswire/ — CardioPharma Inc. (the “Company”), a specialty pharmaceutical company focused on drug development for cardiovascular diseases, announced that on August 29, 2023, the United States Patent and Trademark Office (“USPTO”) issued US Patent…



